Ensysce Biosciences, Inc. (ENSC)

NASDAQ: ENSC · Real-Time Price · USD

2.070

-0.120 (-5.48%)

At close: May 13, 2025, 4:00 PM

2.190

+0.120 (5.80%)

Pre-market: May 14, 2025, 7:23 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Abuse and Overdose Resistant Pain Technology	5.21M	Log In	Log In	Log In
Abuse and Overdose Resistant Pain Technology Growth	133.58%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	5.21M	Log In	Log In	Log In
United States Growth	133.58%	Log In	Log In	Log In